ATE449080T1 - 4-phenyl-6-substituierte pyrimidin-2- carbonitrilderivate - Google Patents
4-phenyl-6-substituierte pyrimidin-2- carbonitrilderivateInfo
- Publication number
- ATE449080T1 ATE449080T1 AT06806788T AT06806788T ATE449080T1 AT E449080 T1 ATE449080 T1 AT E449080T1 AT 06806788 T AT06806788 T AT 06806788T AT 06806788 T AT06806788 T AT 06806788T AT E449080 T1 ATE449080 T1 AT E449080T1
- Authority
- AT
- Austria
- Prior art keywords
- phenyl
- substituted pyrimidine
- carbonitrile derivatives
- carbonitrile
- derivatives
- Prior art date
Links
- -1 4-PHENYL-6-SUBSTITUTED PYRIMIDINE-2 CARBONITRILE Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05108810 | 2005-09-23 | ||
| PCT/EP2006/066562 WO2007039470A1 (en) | 2005-09-23 | 2006-09-21 | 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE449080T1 true ATE449080T1 (de) | 2009-12-15 |
Family
ID=35466129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06806788T ATE449080T1 (de) | 2005-09-23 | 2006-09-21 | 4-phenyl-6-substituierte pyrimidin-2- carbonitrilderivate |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1928842B1 (de) |
| JP (1) | JP5060484B2 (de) |
| KR (1) | KR20080046716A (de) |
| CN (1) | CN101268058B (de) |
| AR (1) | AR056086A1 (de) |
| AT (1) | ATE449080T1 (de) |
| AU (1) | AU2006298775A1 (de) |
| BR (1) | BRPI0616186A2 (de) |
| CA (1) | CA2621040C (de) |
| DE (1) | DE602006010581D1 (de) |
| ES (1) | ES2334714T3 (de) |
| IL (1) | IL189893A0 (de) |
| NO (1) | NO20081128L (de) |
| NZ (1) | NZ566475A (de) |
| PE (1) | PE20070438A1 (de) |
| TW (1) | TW200745055A (de) |
| WO (1) | WO2007039470A1 (de) |
| ZA (1) | ZA200802088B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101078098B1 (ko) | 2003-01-14 | 2011-10-28 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서의 １,２,３-삼치환된 아릴 및 헤테로아릴유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된장애의 예방 및 치료 |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| AR045697A1 (es) | 2003-07-14 | 2005-11-09 | Arena Pharm Inc | Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| CN101479269A (zh) * | 2006-06-23 | 2009-07-08 | 阿斯利康(瑞典)有限公司 | 蝶啶衍生物及其作为组织蛋白酶抑制剂的用途 |
| AU2009279787B2 (en) | 2008-08-04 | 2014-05-29 | Chdi Foundation, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| EP2528441A4 (de) | 2010-01-25 | 2013-07-10 | Chdi Foundation Inc | Bestimmte kynurenin-3-monooxygenase-hemmer, pharmazeutische zusammensetzungen daraus und verwendungsverfahren dafür |
| SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| US8524710B2 (en) * | 2010-11-05 | 2013-09-03 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
| US9981918B2 (en) | 2011-08-30 | 2018-05-29 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| JP2014525443A (ja) | 2011-08-30 | 2014-09-29 | シーエイチディーアイ ファウンデーション，インコーポレーテッド | キヌレニン−３−モノオキシゲナーゼインヒビター、医薬組成物、およびこれらの使用方法 |
| EP2840083B1 (de) * | 2012-04-17 | 2017-09-13 | Astellas Pharma Inc. | Nitrogenierte bicyclische aromatische heterocyclische verbindung |
| KR20170026633A (ko) | 2014-07-17 | 2017-03-08 | 씨에이치디아이 파운데이션, 인코포레이티드 | Hiv-관련 장애의 치료 방법 및 치료용 조성물 |
| PL3242666T3 (pl) | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| HUE060476T2 (hu) | 2015-06-22 | 2023-03-28 | Arena Pharm Inc | (R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| JP7271566B2 (ja) * | 2018-03-28 | 2023-05-11 | ハンリム ファーマシューティカル カンパニー リミテッド | ２－シアノピリミジン－４－イル カルバメート誘導体もしくはウレア誘導体またはその塩及びそれを含む医薬組成物 |
| US12156866B2 (en) | 2018-06-06 | 2024-12-03 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR036375A1 (es) * | 2001-08-30 | 2004-09-01 | Novartis Ag | Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos |
| GB0121033D0 (en) * | 2001-08-30 | 2001-10-24 | Novartis Ag | Organic compounds |
| SE0201976D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| SE0201980D0 (sv) * | 2002-06-24 | 2002-06-24 | Astrazeneca Ab | Novel compounds |
| GB0220187D0 (en) * | 2002-08-30 | 2002-10-09 | Novartis Ag | Organic compounds |
-
2006
- 2006-09-14 TW TW095134051A patent/TW200745055A/zh unknown
- 2006-09-21 AT AT06806788T patent/ATE449080T1/de not_active IP Right Cessation
- 2006-09-21 JP JP2008531697A patent/JP5060484B2/ja not_active Expired - Fee Related
- 2006-09-21 NZ NZ566475A patent/NZ566475A/en unknown
- 2006-09-21 BR BRPI0616186-3A patent/BRPI0616186A2/pt not_active IP Right Cessation
- 2006-09-21 DE DE602006010581T patent/DE602006010581D1/de active Active
- 2006-09-21 EP EP06806788A patent/EP1928842B1/de not_active Not-in-force
- 2006-09-21 CN CN2006800348456A patent/CN101268058B/zh not_active Expired - Fee Related
- 2006-09-21 ES ES06806788T patent/ES2334714T3/es active Active
- 2006-09-21 KR KR1020087008796A patent/KR20080046716A/ko not_active Withdrawn
- 2006-09-21 CA CA2621040A patent/CA2621040C/en not_active Expired - Fee Related
- 2006-09-21 AU AU2006298775A patent/AU2006298775A1/en not_active Abandoned
- 2006-09-21 WO PCT/EP2006/066562 patent/WO2007039470A1/en not_active Ceased
- 2006-09-22 PE PE2006001151A patent/PE20070438A1/es not_active Application Discontinuation
- 2006-09-25 AR ARP060104157A patent/AR056086A1/es unknown
-
2008
- 2008-03-03 IL IL189893A patent/IL189893A0/en unknown
- 2008-03-04 NO NO20081128A patent/NO20081128L/no not_active Application Discontinuation
- 2008-03-05 ZA ZA200802088A patent/ZA200802088B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006010581D1 (de) | 2009-12-31 |
| BRPI0616186A2 (pt) | 2011-06-07 |
| WO2007039470A1 (en) | 2007-04-12 |
| NZ566475A (en) | 2010-03-26 |
| IL189893A0 (en) | 2008-08-07 |
| CN101268058B (zh) | 2013-02-27 |
| KR20080046716A (ko) | 2008-05-27 |
| TW200745055A (en) | 2007-12-16 |
| JP5060484B2 (ja) | 2012-10-31 |
| HK1124319A1 (en) | 2009-07-10 |
| EP1928842A1 (de) | 2008-06-11 |
| ES2334714T3 (es) | 2010-03-15 |
| CN101268058A (zh) | 2008-09-17 |
| AR056086A1 (es) | 2007-09-19 |
| ZA200802088B (en) | 2008-11-26 |
| AU2006298775A1 (en) | 2007-04-12 |
| JP2009508912A (ja) | 2009-03-05 |
| EP1928842B1 (de) | 2009-11-18 |
| CA2621040A1 (en) | 2007-04-12 |
| PE20070438A1 (es) | 2007-06-13 |
| CA2621040C (en) | 2014-01-28 |
| NO20081128L (no) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL2000323A1 (nl) | Pyrimidine-derivaten. | |
| MA28824B1 (fr) | Derives de pyrimidine | |
| MA28813B1 (fr) | Derives de pyrimidine | |
| EP1724267A4 (de) | Pyrimidinderivat | |
| IS8578A (is) | 3- karbamoýl - 2- pýridón afleiður | |
| ATE520670T1 (de) | Pyridazinderivate | |
| DK1725553T3 (da) | Tetrahydropyridoindolderivater | |
| ATE540935T1 (de) | Chinazolinderivate | |
| ATE383361T1 (de) | Pyrrazolopyrimidinderivate | |
| GB0525080D0 (en) | Pyrimidine derivatives | |
| GB0525083D0 (en) | Pyrimidine derivatives | |
| ATE417830T1 (de) | Sulfonylbenzimidazolderivate | |
| ATE449080T1 (de) | 4-phenyl-6-substituierte pyrimidin-2- carbonitrilderivate | |
| ATE487718T1 (de) | Substituierte bizyklische pyrimidonderivate | |
| GB0525081D0 (en) | Pyrimidine derivatives | |
| ATE485294T1 (de) | Azaindol-2-carboxamid-derivate | |
| ATE430142T1 (de) | Phenylpiperazin-methanon-derivate | |
| ATE527255T1 (de) | Aryl-isoxazol-4-yl-imidazol-derivate | |
| DE502006001027D1 (de) | Cyanuraten | |
| DK1971588T3 (da) | Tiglien-3-onderivater | |
| ATE404542T1 (de) | 4-phenylpyrimidin-2-carbonitrilderivate | |
| DK1740574T3 (da) | 4-amino-5-cyanopyrimidinderivater | |
| DE602006014973D1 (de) | Neuartige cercosporamidderivate | |
| EP1867636A4 (de) | Pyridylmethylsulfonderivat | |
| EP1935879A4 (de) | Substituiertes cycloalkenderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |